Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Indian J Otolaryngol Head Neck Surg ; 75(2): 523-528, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-36540727

RESUMO

The aim of this study was to find out the association of sinonasal candidiasis and Covid-19 infection. A prospective observational study was conducted at a tertiary care centre from April to September 2021, involving all patients with invasive candidiasis of the paranasal sinuses having a history of Covid-19 infection. A total of 18 patients of covid associated sinonasal candidiasis among the 475 cases of fungal rhinosinusitis were studied. All patients had involvement of nose and sinuses and 2 patients had orbital involvement with no loss of vision, while 3 had intracranial extensions and 1 had pulmonary involvement. Mandible was involved in 1 patient alone, while the maxilla and palate were involved in 5 patients. 15 patients were hypertensive, 12 diabetics and 1 had aplastic anaemia. Cultures showed that 8 patients had C. parapsilosis, 5 had C. albicans, 3 had C. tropicalis and 2 had mixed fungal infections. All patients underwent surgical debridement and antifungal administration. They were followed up for a minimum of 3 months. There was only one mortality (with aplastic anaemia), rest 17 were disease free at the time of writing this article. This is perhaps the first case series of post covid sinonasal candidiasis in the world. Invasive sinonasal candidiasis is a newer sequela of COVID-19 infection. Uncontrolled diabetes and over-zealous use of steroids at the time of Covid-19 are few of the known risk factors. Early surgical intervention and anti-fungal treatment should be sought for management.

2.
Indian J Otolaryngol Head Neck Surg ; 75(2): 557-562, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-36571095

RESUMO

To study the possible association between invasive fungal sinusitis (aspergillosis) and coronavirus disease. An observational study was conducted at a tertiary care centre over 6 months, involving all patients with aspergillosis of the paranasal sinuses suffering from or having a history of COVID-19 infection. 92 patients presented with aspergillosis, all had an association with COVID-19 disease. Maxillary sinus (100%) was the most common sinus affected. Intraorbital extension was seen in 34 cases, while intracranial extension was seen in 5 cases. Diabetes mellitus was present in 75 of 92 cases. All had a history of steroid use during their coronavirus treatment. New manifestations of COVID-19 are appearing over time. The association between coronavirus and aspergillosis of the paranasal sinuses must be given serious consideration. Uncontrolled diabetes and overzealous use of steroids are two main factors aggravating the illness, and both of these must be properly checked.

3.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 2): 1597-1604, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-36452847

RESUMO

Chronic inflammatory disorders of the upper airways are extremely prevalent and they have a major impact on public health.To assess the change in pulmonary function tests in patients of chronic rhinosinusitis undergoing functional endoscopic sinus surgery pre operatively and post operatively.To evaluate the difference in mean of FEV1, FEV1%, FVC, FVC%, FEV1/FVC in patients of chronic rhinosinusitis undergoing functional endoscopic sinus surgery.Prospective observational study.From July 2019 to September 2020 in Department of ENT and Head & Neck surgery, SMS Medical College, Jaipur.There was a significant improvement in the mean FEV1, FEV1%, FVC, and FVC% values post-surgically (p < 0.05). In our study, there was also a significant improvement in the FEV1/FVC value at one month postoperatively, reflecting the effect of FESS on relieving the symptomatic lower airway obstruction.Our study concludes that following Functional Endoscopic Sinus Surgery there is significant improvement in pulmonary function tests reflecting the improvement of asymptomatic lower airway disease in cases of chronic rhinosinusitis.

4.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 2): 3469-3472, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34631494

RESUMO

Coronavirus disease 2019 (COVID-19) has been found to be associated with mucormycosis in few parts of the world, especially India. It is important to look for reasons for this upsurge of cases so that other countries may take proper steps to prevent it. A prospective clinico-demographic study was conducted in SMS Medical College, Jaipur, India from April to May 2021. All patients (235) with COVID associated mucormycosis (CAM) were studied in detail with reference to their diabetic status and steroid intake during treatment of COVID-19. Steroid usage was in 84.3% of patients with methylprednisolone being the most commonly used steroid (66.8%). Majority of the patients had taken steroids for 7-14 days. Diabetes was found in 204 patients and 42.1% of patients were newly diagnosed during/after COVID-19 treatment. The HbA1c levels of diabetic patients ranged from 6.0% to 16.3%. This is perhaps the biggest study in the world shows that the triad of COVID-19, diabetes and steroid usage is a major contributing factor towards mucormycosis. Proper steps should be taken to prevent CAM.

5.
Lung India ; 38(1): 5-11, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33402631

RESUMO

BACKGROUND: Predictors of survival for interstitial lung disease (ILD) in the Indian population have not been studied. The primary objective of the study was to assess the Modified-Gender Age and Physiology (M-GAP) score to predict survival in patients with ILD seen in clinical practice. We also analyzed the role of demographic and radiological characteristics in predicting the survival of patients with ILD. MATERIALS AND METHODS: In the ILD India registry, data were collected from 27 centers across 19 cities in India between March 2012 and June 2015. A single follow-up was conducted at 18 centers who agreed to participate in the follow-up in 2017. M-GAP score (range 0-5) was calculated with the following variables: age (≤60 years 0, 61-65 years 1, and >65 years 2), gender (female 0, male 1), and forced vital capacity% (>75% 0, 50%-75% 1, and >75% 2). A score of 0-3 and score of 4 and 5 were classified into Stage 1 and 2, respectively. Other predictors of survival, such as the history of tuberculosis, smoking, and the presence of honeycombing on computed tomography scan, were also evaluated. RESULTS: Nine hundred and seven patients were contacted in 2017. Among them, 309 patients were lost to follow-up; 399 were alive and 199 had died. M-GAP was significantly associated with survival. Similarly, other predictors of survival were ability to perform spirometry (hazard ratio [HR]: 0.49, 95% confidence interval [CI]: 0.34-0.72), past history of tuberculosis (HR: 1.57, 95% CI: 1.07-2.29), current or past history of smoking (HR: 1.51, 95% CI: 1.06-2.16), honeycombing (HR: 1.81, 95% CI: 1.29-2.55), a diagnosis of connective tissue disease -ILD (HR: 0.41, 95% CI: 0.22-0.76), and sarcoidosis (HR: 0.24, 95% CI: 0.08-0.77). CONCLUSION: In a subgroup of patients with newly diagnosed ILD enrolled in ILD India registry and who were available for follow-up, M-GAP score predicted survival. Honeycombing at the time of diagnosis, along with accurate history of smoking, and previous history of tuberculosis were useful indices for predicting survival.

6.
Clin Respir J ; 12(2): 547-556, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27663282

RESUMO

OBJECTIVE: We aim to describe the data collected from India during phase 3 of the International study of asthma and allergy in childhood (ISAAC) study. Prevalence, severity, and population characteristics associated with rhinitis, rhinoconjunctivitis, and eczema were assessed. METHODS: Children from two age groups (6-7 and 13-14 years) were included in the study as per the ISAAC protocol. The symptoms of allergy and associated features were assessed using a questionnaire. RESULTS: The prevalence of allergic rhinitis among the 6-7 years age group was 11.3%, while it was 24.4% in the 13-14 years age group. The prevalence of allergic rhinoconjunctivitis was 3.9% in the 6-7 years age group and 10.9% in the 13-14 years age group. The prevalence of eczema was 2.8% in the 6-7 years age group and 3.7% in the 13-14 years age group. The passage of trucks near home, parental smoking, use of paracetamol, use of antibiotics, cooking with firewood, and television watching were associated with allergic rhinitis, rhinoconjunctivitis, and eczema. Maternal smoking was the strongest of all the associated features for allergic rhinitis, rhinoconjunctivitis, and eczema, especially in the 6-7 years age group (odds ratio: 1.9, 95% CI: 1.5-2.4; odds ratio: 2.9, 95% CI, 2.2-3.9; and odds ratio: 3.5, 95% CI: 2.6-4.8, respectively). CONCLUSION: Allergic conditions like allergic rhinitis, rhinoconjunctivitis, and eczema are prevalent among Indian children and are associated with environmental tobacco smoke, paracetamol use, antibiotic use, television watching, and outdoor and indoor air pollution.


Assuntos
Conjuntivite Alérgica/epidemiologia , Eczema/epidemiologia , Poluição Ambiental/efeitos adversos , Rinite Alérgica/epidemiologia , Fumar/efeitos adversos , Inquéritos e Questionários , Acetaminofen/administração & dosagem , Acetaminofen/efeitos adversos , Adolescente , Distribuição por Idade , Antibacterianos/administração & dosagem , Antibacterianos/efeitos adversos , Criança , Intervalos de Confiança , Conjuntivite Alérgica/imunologia , Estudos Transversais , Eczema/imunologia , Feminino , Humanos , Índia/epidemiologia , Masculino , Prevalência , Rinite Alérgica/imunologia , Fatores de Risco , Distribuição por Sexo
7.
J Asthma ; 53(3): 238-44, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26365004

RESUMO

OBJECTIVE: Phase three of the International Study of Asthma and Allergy in Children (ISAAC) was carried out at various sites in India. The prevalence of asthma symptoms in school children and the effect of environmental tobacco smoke and traffic pollution on the occurrence of asthma were analysed. METHODS: Two groups of school children, aged 6-7 yr and 13-14 yr, participated according to the ISAAC protocol. Schools were randomly selected and responses to the ISAAC questionnaire were recorded. RESULTS: The prevalence of asthma was 5.35% in the 6-7 yr age group and 6.05% in the 13-14 yr age group. The odds ratios (ORs) for the risk of asthma in children with exposure to mild, moderate and heavy traffic pollution compared with minimal traffic pollution were 1.63 (95% CI: 1.43, 1.85), 1.71 (95% CI: 1.49, 1.96) and 1.53 (95% CI: 1.31, 1.78), respectively, in the younger group. Similarly, in the older group, they were 1.19 (95% CI: 1.04, 1.36), 1.51 (95% CI: 1.31, 1.75) and 1.51 (95% CI: 1.29, 1.76). Asthma was associated with maternal smoking [6-7 yr group: OR = 2.72 (2.05, 3.6); 13-14 yr group: OR = 2.14 (1.72, 2.66)] and paternal smoking [6-7 yr group: OR = 1.9 (1.70, 2.11); 13-14 yr group: OR = 1.21 (1.09, 1.34)]. CONCLUSIONS: The prevalence of asthma was lower in the 6-7 than the 13-14 yr age group. Environmental tobacco smoke and traffic pollution were the factors most strongly associated with asthma in Indian children.


Assuntos
Asma/epidemiologia , Pais , Fumar/epidemiologia , Poluição por Fumaça de Tabaco/estatística & dados numéricos , Emissões de Veículos , Adolescente , Criança , Feminino , Humanos , Índia , Masculino , Prevalência , Características de Residência , Sons Respiratórios , Fatores de Risco
8.
Lung India ; 32(2): 102-6, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25814792

RESUMO

BACKGROUND: Anthracosis is the black pigmentation of the mucosal lining of the tracheo-bronchial tree. The significance of this finding is not known and often ignored. The aim of the present study is to find the association of anthracosis with demographic variables, biomass fuel and occupational exposure, respiratory diseases, radiological pattern and functional morbidity. MATERIALS AND METHODS: Enrolment of the subjects for the study was done at SMS hospital, Jaipur. Patients with anthracosis evident on bronchoscopy were included as the cases. Patients without anthracosis on bronchoscopy, matched according to age, gender and smoking habits, were included in the control group. Subjects in both the arms completed a questionnaire and also underwent computed tomography (CT) of the chest and six minute walk test (6MWT). RESULTS: Thirty cases and 53 controls were included in the study. The patients with anthracosis presented with symptoms ranging from cough (76.65%), hemoptysis (46.6%), fever (26.6%), dyspnea (90%) and malaise (73.3%). Biomass fuel exposure for the cases was 35.13 ± 55.86 hours in a year and for the controls was 28.15 ± 40.09 hours in a year (P > 0.05). Stone mining was significantly associated with anthracosis (P < 0.05). CT chest revealed fibrosis (43.3%), consolidation (33.3%), cavitation (16.6%) and mass (46.6%) in the cases. Sixty percent of cases and 15% of controls were diagnosed to have either old or active pulmonary tuberculosis (P < 0.05). CONCLUSIONS: Anthracosis is associated with pulmonary tuberculosis. Biomass exposure is not significantly associated with anthracosis. Post tubercular fibrosis is more common on CT chest of patients with anthracosis.

9.
Lung India ; 29(3): 212-6, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22919157

RESUMO

BACKGROUND: It is thought that price increase in tobacco products leads to reduced consumption. Though many studies have substantiated this concept, it has not been well studied in India. Recently, price of tobacco products was increased due to ban on plastic sachets of chewing tobacco and increased tax in Rajasthan. This study was designed to evaluate the effect of price rise on overall consumption of tobacco in Jaipur city, Rajasthan. MATERIALS AND METHODS: This study was carried out in Jaipur city. Two-staged stratified sampling was used. In the first phase of study, cost and consumption of various tobacco products in the months of February and April were enquired from 25 retail tobacco shops. In the second phase, tobacco consumption was enquired from 20 consecutive consumers purchasing any tobacco product from all the above retail tobacco shops. The data were statistically analyzed using descriptive statistics and paired "t" test. RESULTS: The comparison of prices of tobacco products between February and April revealed that the price of cigarette, bidi, and chewing tobacco has increased by 19%, 21%, and 68%, respectively. Average decrease in sales of cigarettes, bidi, and chewing tobacco at shops included in the study were 14%, 23%, and 38%, respectively. The consumers purchasing tobacco also reported decreased consumption. Chewing tobacco showed the maximum reduction (21%). Consumption of cigarette and bidi has also reduced by 15% and 13%, respectively. CONCLUSION: It may be concluded that reduction in consumption is associated with increased price of tobacco products. Reduced consumption is comparative to the magnitude of price increase.

10.
J Assoc Physicians India ; 59: 360-4, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21751589

RESUMO

AIMS: To study the awareness, attitude and behavior of patients with chronic disease in those who come for follow-up, about nature of their disease, compliance to drugs and precautions. PATIENTS AND METHODS: Patients attending medical outdoor with a prescription documents (discharge cards, pensioner diary, prescription letter etc.) bearing diagnosis of the chronic disease in question based on standard criteria were studied for a period of six month. Patient with chronic disease completed a questionnaire containing questions about nature of disease, important precautions and compliance to the treatment. RESULTS: Of the 63 coronary artery disease (CAD) patients 27 (42.8%) were not aware of having heart disease ever in the life. Twenty nine (44%) CAD patients noncompliant for medicines during last one month. Among 84 hypertensive patients only 58 (69%) knew they had hypertension and 54 (64.2%) compliant with medicine. Only 40 (47.6 %) out of 84 avoided salt in food. Though, out of 36 diabetic patients 34 (94.4%) percent knew they had diabetes, still 19 (52.7%) stopped medicine during last month. Among 29 chronic obstructive pulmonary disease (COPD) patients only 6 (20.6%) knew they had COPD and another 17(58.6%) knew they had respiratory problem. Only 5 (17.2%) COPD patients remembered the no-smoking advice. Out of 23 CVA patients 17 (74%) knew that they have paralysis and 8 (34.7%) stopped medication during last month. CONCLUSION: It is concluded that majority of patients were ignorant about their disease, importance of compliance to medicines and about precautions of the disease. CAD patients were most ignorant people among chronic patients. It emphasizes the need of proper patient education


Assuntos
Doença Crônica/tratamento farmacológico , Conhecimentos, Atitudes e Prática em Saúde , Letramento em Saúde , Cooperação do Paciente/estatística & dados numéricos , Medicamentos sob Prescrição/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos Transversais , Dieta , Feminino , Seguimentos , Comportamentos Relacionados com a Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Ambulatório Hospitalar , Fatores de Risco , Inquéritos e Questionários
11.
Indian J Chest Dis Allied Sci ; 53(2): 81-5, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21545068

RESUMO

BACKGROUND: Sildenafil has been found to improve exercise capacity and haemodynamic parameters in patients with various pulmonary disorders. This study was undertaken to evaluate its efficacy in severe chronic obstructive pulmonary disease (COPD). METHODS: In this double-blind, randomised, placebo-controlled study, 37 patients with severe COPD received either sildenafil or placebo for 12 weeks. Distance covered in six-minute walk test (6MWD) was taken as primary end-point. Pulmonary artery pressure (PAP) was measured as secondary end point. RESULTS: Thirty-three patients (15 in sildenafil arm and 18 in placebo arm) completed the study. Non-parametric tests were used for comparison. There was significant increase in 6MWD from baseline after three months of follow-up in sildenafil users (median change in distance covered in six-minute walk test (delta6MWD) = 190m) as compared to placebo users (delta6MWD = 0m, p < 0.05). The PAP decreased significantly (chi2 = 14.94, p < 0.05) in sildenafil group after three months, while it did not change significantly among placebo group (chi2 = 3.84, p > 0.05). CONCLUSION: Sildenafil improved 6MWD and PAP in patients with severe COPD.


Assuntos
Inibidores da Fosfodiesterase 5/uso terapêutico , Piperazinas/uso terapêutico , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico , Sulfonas/uso terapêutico , Idoso , Análise de Variância , Pressão Sanguínea/fisiologia , Método Duplo-Cego , Tolerância ao Exercício/fisiologia , Volume Expiratório Forçado , Humanos , Pessoa de Meia-Idade , Piperazinas/efeitos adversos , Artéria Pulmonar/fisiologia , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Purinas/efeitos adversos , Purinas/uso terapêutico , Citrato de Sildenafila , Estatísticas não Paramétricas , Sulfonas/efeitos adversos , Caminhada
12.
J Asthma ; 46(2): 118-21, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19253114

RESUMO

AIMS: This study was conducted to evaluate pulmonary effects of traffic pollution on traffic police. METHODS: The traffic police working in Jaipur city were given a predetermined respiratory health questionnaire, and their clinical profile and lung functions were measured. RESULTS: This study showed that there were prominent respiratory symptoms and reduced forced expiratory volume in 1 second (FEV(1)) in subjects exposed to traffic pollution. When smokers were excluded, it showed a significant difference in FEV(1) data of non-smoking subjects exposed to traffic generated pollution and those not exposed. The difference observed was 95.3 +/- 13.6 versus 87.8 +/- 0.95%, respectively, and 95%CI = 4.420-10.517, p = 0.001. CONCLUSIONS: Respiratory morbidity with respect to lung function tests is observed more in groups working in heavy traffic than the control group.


Assuntos
Poluição do Ar/efeitos adversos , Polícia/estatística & dados numéricos , Transtornos Respiratórios/induzido quimicamente , Transtornos Respiratórios/epidemiologia , Emissões de Veículos/intoxicação , Adulto , Tosse/epidemiologia , Dispneia/epidemiologia , Volume Expiratório Forçado/fisiologia , Humanos , Índia/epidemiologia , Pulmão/efeitos dos fármacos , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Transtornos Respiratórios/fisiopatologia , Sons Respiratórios/diagnóstico , Fumar/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA